Here, we identified TEAD4 as the key partner with TAZ to regulate SOX2 expression in HNSCC through IP assay, which was also consistent with its oncogenic functions and aberrant upregulation in cancer27,34. Here, TEAD4 is linked to head and neck squamous cell carcinoma.